Retinopathy of prematurity (ROP) is a significant cause of potentially preventable blindness
in preterm infants worldwide. It is a disease caused by abnormal retinal vascularization that …

Aim To study the outcomes of very preterm infants with hyperglycaemia treated with Insulin.
Methods This is a systematic review of randomised controlled trials (RCTs) and …

Background Evidence is needed to inform thresholds for glycemic management in neonatal
encephalopathy (NE). We investigated how severity and duration of dysglycemia relate to …

Through a meta-analysis, we aimed to investigate whether neonatal hyperglycemia was
associated with an increased risk of retinopathy of prematurity (ROP) by summarizing all …

Background and Objectives: There are limited data regarding the incidence and risk factors
for hypoglycemia, hyperglycemia, and unstable glycemia in preterm infants. The aim of the …

Aim Retinopathy of prematurity is a significant global cause of childhood blindness. This
study aims to identify serum biomarkers that are associated with the development of ROP …

Objective In monogenic diabetes due to KCNJ11 and ABCC8 mutations that impair KATP‐
channel function, sulfonylureas improve long‐term glycemic control. Although KATP …

Adequate nutrition and glycemic homeostasis are increasingly recognized as potentially
neuroprotective for the developing brain. In the context of hypoxia-ischemia, evidence is …

Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. ROP occurs in
infants who are born very preterm. In ROP, retinal blood vessel development, which is …

Very preterm infants are at high risk of growth failure. Poor weight gain is a prominent risk
factor for retinopathy of prematurity (ROP) and optimizing nutrition could potentially promote …